Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A.

Coppola A, Santagostino E, Hassan HJ, Molinari AC, Santoro RC, Tagliaferri A, Morfini M, Di Minno G.

Blood Transfus. 2017 May;15(3):281-282. doi: 10.2450/2017.0285-16. Epub 2017 Mar 2. No abstract available.

2.

Risk factors for contact lens-induced papillary conjunctivitis associated with silicone hydrogel contact lens wear.

Tagliaferri A, Love TE, Szczotka-Flynn LB.

Eye Contact Lens. 2014 May;40(3):117-22. doi: 10.1097/ICL.0000000000000019.

3.

Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity.

Bellan M, Guzzaloni G, Rinaldi M, Merlotti E, Ferrari C, Tagliaferri A, Pirisi M, Aimaretti G, Scacchi M, Marzullo P.

Cardiovasc Diabetol. 2014 Mar 11;13:57. doi: 10.1186/1475-2840-13-57.

4.

Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

Coppola A, Tagliaferri A, Calizzani G, Candura F, Franchini M, Ruosi C, Grazzini G, Di Minno G.

Blood Transfus. 2013 Sep;11 Suppl 4:s101-9. doi: 10.2450/2013.016s. Review. No abstract available.

5.

Meditation training for people with amyotrophic lateral sclerosis and their caregivers.

Pagnini F, Di Credico C, Gatto R, Fabiani V, Rossi G, Lunetta C, Marconi A, Fossati F, Castelnuovo G, Tagliaferri A, Banfi P, Corbo M, Sansone V, Molinari E, Amadei G.

J Altern Complement Med. 2014 Apr;20(4):272-5. doi: 10.1089/acm.2013.0268. Epub 2013 Dec 11.

6.

Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

Santagostino E, Messina M, Tagliaferri A, Iorio A, Morfini M.

Blood Transfus. 2013 Apr;11(2):272-80. doi: 10.2450/2012.0158-12. Epub 2013 Jan 23.

7.

The expanding role of prophylaxis with recombinant activated factor VII.

Tagliaferri A, Franchini M.

Blood Transfus. 2013 Jan;11(1):12-3. doi: 10.2450/2012.0061-12. Epub 2012 Jul 4. No abstract available.

8.

A multicenter study to map genes for Fuchs endothelial corneal dystrophy: baseline characteristics and heritability.

Louttit MD, Kopplin LJ, Igo RP Jr, Fondran JR, Tagliaferri A, Bardenstein D, Aldave AJ, Croasdale CR, Price MO, Rosenwasser GO, Lass JH, Iyengar SK; FECD Genetics Multi-Center Study Group.

Cornea. 2012 Jan;31(1):26-35. doi: 10.1097/ICO.0b013e31821c9b8f.

9.

Size Evolution of Ordered SiGe Islands Grown by Surface Thermal Diffusion on Pit-Patterned Si(100) Surface.

Vanacore GM, Zani M, Bollani M, Colombo D, Isella G, Osmond J, Sordan R, Tagliaferri A.

Nanoscale Res Lett. 2010 Sep 30;5(12):1921-1925.

10.

Ordered Arrays of SiGe Islands from Low-Energy PECVD.

Bollani M, Bonera E, Chrastina D, Fedorov A, Montuori V, Picco A, Tagliaferri A, Vanacore G, Sordan R.

Nanoscale Res Lett. 2010 Sep 7;5(12):1917-20. doi: 10.1007/s11671-010-9773-0.

11.

Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.

Rivolta GF, Di Perna C, Franchini M, Riccardi F, Ippolito L, Lombardi M, Tagliaferri A.

Blood Transfus. 2010 Jan;8(1):66-8. doi: 10.2450/2009.0078-09. No abstract available.

12.

Secondary prophylaxis in adolescent and adult haemophiliacs.

Tagliaferri A, Di Perna C, Rivolta GF.

Blood Transfus. 2008 Sep;6 Suppl 2:s17-20. Review.

13.

The management of hemophilia in elderly patients.

Franchini M, Tagliaferri A, Mannucci PM.

Clin Interv Aging. 2007;2(3):361-8. Review.

Supplemental Content

Loading ...
Support Center